Fig. 3From: Evaluating cost per remission and cost of serious adverse events of advanced therapies for ulcerative colitisCost per remission at 52 weeks among patients with UC treated with an advanced therapy. BID twice daily, IV intravenous, PO by mouth, Q2W every 2 weeks, Q4W every 4 weeks, Q8W every 8 weeks, SC subcutaneous, UC ulcerative colitisBack to article page